pembrolizumab and ido inhibitors in bladder cancer
Published 3 years ago • 38 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
5:30
pembrolizumab plus gemcitabine in combination with radiation for bladder cancer
-
4:42
pembrolizumab for patients with high-risk, non-muscle invasive bladder cancer
-
0:38
the role of pembrolizumab and hif-2α inhibitors in renal carcinoma
-
2:48
an overview of pd-1 inhibitors in bladder cancer
-
9:43
integrating immuno-oncology and targeted therapy for bladder cancer in practice
-
10:44
earlier use of immune checkpoint inhibitors to adjuvant and non muscle invasive bladder cancer
-
3:51
is pembrolizumab alone sufficient to treat bladder cancer?
-
0:56
bladder cancer: combining ido inhibitors with immunotherapy
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
3:52
pembrolizumab and indoximod for melanoma
-
1:33
ambassador: pembrolizumab for locally advanced bladder cancer
-
20:52
bladder cancer and immunotherapy
-
3:18
second line pembrolizumab vs. chemotherapy in bladder cancer: insights from asco 2017
-
1:40
dr. luke on combining an ido inhibitor with nivolumab in advanced cancers
-
4:45
ido inhibitors for melanoma
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
6:00
use of immune checkpoint inhibitors for bladder cancer